PHAT Phathom Pharmaceuticals Inc

USD 3.90 -0.13 ( -3.23%)
Icon

Phathom Pharmaceuticals Inc (PHAT) Financial Statements

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 3.90

-0.13 (-3.23%)

N/A

1.19M

USD 23.14(+493.41%)

USD 17.50 (+348.72%)

Icon

PHAT

Phathom Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 3.90
-0.13 ( -3.23%)

Phathom Pharmaceuticals Inc (PHAT) Annual Income Statement (USD)

PHAT Quarterly Financials (USD)

Frequently Asked Questions About Phathom Pharmaceuticals Inc (PHAT) Stock

Phathom Pharmaceuticals Inc's (PHAT) last reported annual revenue was USD 682000.00.

Phathom Pharmaceuticals Inc's (PHAT) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A

Phathom Pharmaceuticals Inc's(PHAT) is not profitable as of its last reported annual financials.

The net profit margin for Phathom Pharmaceuticals Inc's(PHAT) from its laster reported year is -29558.94%

The return on equity (ROE) for Phathom Pharmaceuticals Inc's(PHAT) from its last reported annual financials is : N/A

The return on assets (ROA) for Phathom Pharmaceuticals Inc's(PHAT) from its last reported annual financials is : N/A

The return on invested capital (ROIC) for Phathom Pharmaceuticals Inc's(PHAT) from its last reported annual financials is : N/A

The Debt to Equity ratio for Phathom Pharmaceuticals Inc's(PHAT) from its last reported annual financials is : N/A

The dividend yield for Phathom Pharmaceuticals Inc's(PHAT) from its laster reported year is N/A

Phathom Pharmaceuticals Inc's(PHAT) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...